BioPharma Credit (LON:BPCR) Stock Falls 0.8% – Time to Sell?

Shares of BioPharma Credit (LON:BPCR – Get Free Report) dropped 0.8% during trading on Thursday. The company traded as low as GBX 0.97 and last traded at GBX 0.97. 6,336,127 shares traded hands during mid-day trading, an increase of 331% from the average session volume of 1,469,651 shares. The stock had previously closed at GBX 0.98.

BioPharma Credit Trading Down 0.2%

The company has a market cap of £10.89 million, a PE ratio of 0.10 and a beta of 0.23. The firm’s 50-day simple moving average is GBX 0.97 and its two-hundred day simple moving average is GBX 0.96.

Insider Activity

In related news, insider Graeme Proudfoot purchased 70,000 shares of the firm’s stock in a transaction on Tuesday, September 29th. The stock was acquired at an average price of GBX 99 per share, with a total value of £69,300. Corporate insiders own 0.09% of the company’s stock.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.